Clinical Trial Detail

NCT ID NCT03311308
Title A Trial of Pembrolizumab and Metformin Versus Pembrolizumab Alone in Advanced Melanoma
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Yana Najjar
Indications

melanoma

Therapies

Metformin + Pembrolizumab

Pembrolizumab

Age Groups: senior adult

No variant requirements are available.